Commonwealth Coat of Arms of Australia

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019

PB 114 of 2019

made under subsection 98C(1) of the

National Health Act 1953

Compilation No. 43

Compilation date: 1 May 2024

Includes amendments: F2024L00500

Registered: 3 May 2024

About this compilation

This compilation

This is a compilation of the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 that shows the text of the law as amended and in force on 1 May 2024 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.

Selfrepealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

 

 

 

Contents

Part 1—Preliminary

1 Name

3 Authority

5 Simplified outline of this instrument

6 Definitions

Part 2—Commonwealth price for pharmaceutical benefits supplied by approved medical practitioners

7 Commonwealth price for pharmaceutical benefits supplied by approved medical practitioners

Part 3—Conditions on payments for pharmaceutical benefits supplied by approved pharmacists and approved medical practitioners

8 Scope of this Part

9 Condition on payment for supply of certain pharmaceutical items

10 Payment for supply of certain pharmaceutical benefits in complete packs

Schedule 1—Readyprepared pharmaceutical benefits that are mixtures of readyprepared ingredients

Schedule 2—Unstable or sterile ingredients used for extemporaneouslyprepared pharmaceutical benefits

Schedule 3—Pharmaceutical benefits for which a dangerous drug fee applies

Schedule 4—Pharmaceutical benefits to be supplied as complete packs only

Schedule 5—Standard formula preparations

1 Standard formula preparations

Endnotes

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Part 1Preliminary

 

1  Name

 (1) This instrument is the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019.

 (2) This instrument may also be cited as PB 114 of 2019.

3  Authority

  This instrument is made under subsection 98C(1) of the National Health Act 1953.

5  Simplified outline of this instrument

The Commonwealth price for pharmaceutical benefits supplied by an approved medical practitioner is worked out in the same way as the Commonwealth price for those benefits supplied by an approved pharmacist.

The Commonwealth will pay an approved medical practitioner or an approved pharmacist for supply of a pharmaceutical benefit only if certain conditions are met. They are as follows:

 (a) if a determination under subsection 85(6) of the Act specifies a brand of the benefit, payment will be made only for supply of that brand of the benefit;

 (b) if the benefit is specified in Schedule 4 to this instrument, payment will be made for supply of the benefit only if it is supplied in a complete pack.

Schedules 1, 2, 3 and 5 list pharmaceutical benefits and ingredients of pharmaceutical benefits for which particular rules apply for working out the Commonwealth price (whether the benefits are supplied by an approved medical practitioner or an approved pharmacist).

Schedule 4 lists pharmaceutical benefits that must be supplied in complete packs by an approved medical practitioner or an approved pharmacist for the practitioner or pharmacist to be paid by the Commonwealth for the supply.

6  Definitions

  In this instrument:

Act means the National Health Act 1953.

approved medical practitioner has the meaning given by subsection 84(1) of the Act.

approved pharmacist has the meaning given by subsection 84(1) of the Act.

brand has the meaning given by subsection 84(1) of the Act.

extemporaneouslyprepared pharmaceutical benefit has the meaning given by subsection 6(1) of the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020).

listed drug has the meaning given by subsection 84(1) of the Act.

pharmaceutical benefit has the meaning given by subsection 84(1) of the Act.

pharmaceutical item has the meaning given by section 84AB of the Act.

Part 2Commonwealth price for pharmaceutical benefits supplied by approved medical practitioners

 

7  Commonwealth price for pharmaceutical benefits supplied by approved medical practitioners

 (1) For the purposes of paragraph 98C(1)(a) of the Act, this section provides for the manner of ascertaining the Commonwealth price for a quantity, or number of units, of a pharmaceutical benefit supplied by an approved medical practitioner, for the purposes of a payment to the practitioner in respect of the supply.

 (2) The Commonwealth price is to be ascertained in the same manner as the Commonwealth price for the supply would have been worked out under the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020) if the supply had been made by an approved pharmacist.

 (3) Schedules 1, 2, 3 and 5 identify pharmaceutical benefits and ingredients in relation to which particular rules for ascertaining the Commonwealth price apply.

Note: Those rules are in the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020), which is relevant because of subsection (2) of this section.

Part 3Conditions on payments for pharmaceutical benefits supplied by approved pharmacists and approved medical practitioners

 

8  Scope of this Part

  For the purposes of paragraph 98C(1)(b) of the Act, this Part sets out the conditions subject to which payments will be made by the Commonwealth in respect of the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners.

9  Condition on payment for supply of certain pharmaceutical items

  If a determination under subsection 85(6) of the Act is in force for a brand of a pharmaceutical item consisting of a drug or medicinal preparation, payments will be made by the Commonwealth in respect of the supply of the drug or preparation only if that brand is supplied.

10  Payment for supply of certain pharmaceutical benefits in complete packs

  Payments will be made by the Commonwealth in respect of the supply of a listed drug in a form described in columns 1 and 2 of an item of Schedule 4 only if the quantity supplied is the quantity contained in a unit of the size described in column 2 of the item (even if the prescription for the supply is for supply of a lesser quantity).

Schedule 1Readyprepared pharmaceutical benefits that are mixtures of readyprepared ingredients

Note: See subsection 7(3).

 

 

 

Readyprepared pharmaceutical benefits that are mixtures of readyprepared ingredients

Column 1
Listed drug with water purified BP

Column 2
Form

Amoxicillin

Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL

Amoxicillin

Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL

Amoxicillin

Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL

Amoxicillin

Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL

Amoxicillin with clavulanic acid

Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL

Amoxicillin with clavulanic acid

Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 50 mL (S19A)

Amoxicillin with clavulanic acid

Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL

Azithromycin

Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL

Cefaclor

Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Cefaclor

Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

Cefalexin

Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Cefalexin

Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL

Cefuroxime

Powder for oral suspension 125 mg (as axetil) per 5 mL, 70 mL (S19A)

Clarithromycin

Powder for oral liquid 250 mg per 5 mL, 50 mL

Erythromycin

Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL

Erythromycin

Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL

Flucloxacillin

Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL

Flucloxacillin

Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL

Fluconazole

Powder for oral suspension 50 mg in 5 mL, 35 mL

Mycophenolic acid

Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL

Phenoxymethylpenicillin

Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL

Phenoxymethylpenicillin

Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL

Phenoxymethylpenicillin

Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL (s19A)

Valganciclovir

Powder for oral solution 50 mg (as hydrochloride) per mL, 100 mL

Voriconazole

Powder for oral suspension 40 mg per mL, 70 mL

 

Schedule 2Unstable or sterile ingredients used for extemporaneouslyprepared pharmaceutical benefits

Note: See subsection 7(3).

 

 

 

Unstable or sterile ingredients used for extemporaneouslyprepared pharmaceutical benefits

Ingredient

Water for injections—sterilised

 

Schedule 3Pharmaceutical benefits for which a dangerous drug fee applies

Note: See subsection 7(3).

 

 

 

Pharmaceutical benefits for which a dangerous drug fee applies

Column 1
Listed drug

Column 2
Form

Alprazolam

Tablet 250 micrograms

Alprazolam

Tablet 500 micrograms

Alprazolam

Tablet 1 mg

Buprenorphine

Injection (modified release) 8 mg in 0.16 mL prefilled syringe

Buprenorphine

Injection (modified release) 16 mg in 0.32 mL prefilled syringe

Buprenorphine

Injection (modified release) 24 mg in 0.48 mL prefilled syringe

Buprenorphine

Injection (modified release) 32 mg in 0.64 mL prefilled syringe

Buprenorphine

Injection (modified release) 64 mg in 0.18 mL prefilled syringe

Buprenorphine

Injection (modified release) 96 mg in 0.27 mL prefilled syringe

Buprenorphine

Injection (modified release) 100 mg in 0.5 mL prefilled syringe

Buprenorphine

Injection (modified release) 128 mg in 0.36 mL prefilled syringe

Buprenorphine

Injection (modified release) 160 mg in 0.45 mL prefilled syringe

Buprenorphine

Injection (modified release) 300 mg in 1.5 mL prefilled syringe

Buprenorphine

Tablet (sublingual) 400 micrograms (as hydrochloride)

Buprenorphine

Tablet (sublingual) 2 mg (as hydrochloride)

Buprenorphine

Tablet (sublingual) 8 mg (as hydrochloride)

Buprenorphine

Transdermal patch 5 mg

Buprenorphine

Transdermal patch 10 mg

Buprenorphine

Transdermal patch 15 mg

Buprenorphine

Transdermal patch 20 mg

Buprenorphine

Transdermal patch 25 mg

Buprenorphine

Transdermal patch 30 mg

Buprenorphine

Transdermal patch 40 mg

Buprenorphine with naloxone

Film (soluble) 2 mg (as hydrochloride)0.5 mg (as hydrochloride)

Buprenorphine with naloxone

Film (soluble) 8 mg (as hydrochloride)2 mg (as hydrochloride)

Codeine

Tablet containing codeine phosphate hemihydrate 30 mg

Dexamfetamine

Tablet containing dexamfetamine sulfate 5 mg

Fentanyl

Lozenge 200 micrograms (as citrate)

Fentanyl

Lozenge 400 micrograms (as citrate)

Fentanyl

Lozenge 600 micrograms (as citrate)

Fentanyl

Lozenge 800 micrograms (as citrate)

Fentanyl

Tablet (orally disintegrating) 100 micrograms (as citrate)

Fentanyl

Tablet (orally disintegrating) 200 micrograms (as citrate)

Fentanyl

Tablet (orally disintegrating) 400 micrograms (as citrate)

Fentanyl

Tablet (orally disintegrating) 600 micrograms (as citrate)

Fentanyl

Tablet (orally disintegrating) 800 micrograms (as citrate)

Fentanyl

Tablet (sublingual) 100 micrograms (as citrate)

Fentanyl

Tablet (sublingual) 200 micrograms (as citrate)

Fentanyl

Tablet (sublingual) 300 micrograms (as citrate)

Fentanyl

Tablet (sublingual) 400 micrograms (as citrate)

Fentanyl

Tablet (sublingual) 600 micrograms (as citrate)

Fentanyl

Tablet (sublingual) 800 micrograms (as citrate)

Fentanyl

Transdermal patch 1.28 mg

Fentanyl

Transdermal patch 2.063 mg

Fentanyl

Transdermal patch 2.1 mg

Fentanyl

Transdermal patch 2.55 mg

Fentanyl

Transdermal patch 4.125 mg

Fentanyl

Transdermal patch 4.2 mg

Fentanyl

Transdermal patch 5.10 mg

Fentanyl

Transdermal patch 7.65 mg

Fentanyl

Transdermal patch 8.25 mg

Fentanyl

Transdermal patch 8.4 mg

Fentanyl

Transdermal patch 10.20 mg

Fentanyl

Transdermal patch 12.375 mg

Fentanyl

Transdermal patch 12.6 mg

Fentanyl

Transdermal patch 16.5 mg

Fentanyl

Transdermal patch 16.8 mg

Hydromorphone

Injection containing hydromorphone hydrochloride 2 mg in 1 mL

Hydromorphone

Injection containing hydromorphone hydrochloride 10 mg in 1 mL

Hydromorphone

Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL

Hydromorphone

Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL (S19A)

Hydromorphone

Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL (S19A) (Pharmascience)

Hydromorphone

Tablet containing hydromorphone hydrochloride 2 mg

Hydromorphone

Tablet containing hydromorphone hydrochloride 4 mg

Hydromorphone

Tablet containing hydromorphone hydrochloride 8 mg

Lisdexamfetamine

Capsule containing lisdexamfetamine dimesilate 20 mg

Lisdexamfetamine

Capsule containing lisdexamfetamine dimesilate 30 mg

Lisdexamfetamine

Capsule containing lisdexamfetamine dimesilate 40 mg

Lisdexamfetamine

Capsule containing lisdexamfetamine dimesilate 50 mg

Lisdexamfetamine

Capsule containing lisdexamfetamine dimesilate 60 mg

Lisdexamfetamine

Capsule containing lisdexamfetamine dimesilate 70 mg

Methadone

Injection containing methadone hydrochloride 10 mg in 1 mL

Methadone

Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 1 L bottle, 1 mL 

Methadone

Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 200 mL bottle, 1 mL

Methadone

Tablet containing methadone hydrochloride 10 mg

Methylphenidate

Capsule containing methylphenidate hydrochloride 10 mg (modified release)

Methylphenidate

Capsule containing methylphenidate hydrochloride 20 mg (modified release)

Methylphenidate

Capsule containing methylphenidate hydrochloride 30 mg (modified release)

Methylphenidate

Capsule containing methylphenidate hydrochloride 40 mg (modified release)

Methylphenidate

Capsule containing methylphenidate hydrochloride 60 mg (modified release)

Methylphenidate

Tablet containing methylphenidate hydrochloride 10 mg

Methylphenidate

Tablet containing methylphenidate hydrochloride 18 mg (extended release)

Methylphenidate

Tablet containing methylphenidate hydrochloride 27 mg (extended release)

Methylphenidate

Tablet containing methylphenidate hydrochloride 36 mg (extended release)

Methylphenidate

Tablet containing methylphenidate hydrochloride 54 mg (extended release)

Morphine

Capsule containing morphine sulfate pentahydrate 10 mg (containing sustained release pellets)

Morphine

Capsule containing morphine sulfate pentahydrate 20 mg (containing sustained release pellets)

Morphine

Capsule containing morphine sulfate pentahydrate 50 mg (containing sustained release pellets)

Morphine

Capsule containing morphine sulfate pentahydrate 100 mg (containing sustained release pellets)

Morphine

Capsule containing morphine sulfate pentahydrate 30 mg (controlled release)

Morphine

Capsule containing morphine sulfate pentahydrate 60 mg (controlled release)

Morphine

Capsule containing morphine sulfate pentahydrate 90 mg (controlled release)

Morphine

Capsule containing morphine sulfate pentahydrate 120 mg (controlled release)

Morphine

Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL

Morphine

Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL

Morphine

Injection containing morphine hydrochloride trihydrate 50 mg in 5 mL

Morphine

Injection containing morphine hydrochloride trihydrate 100 mg in 5 mL

Morphine

Injection containing morphine sulfate pentahydrate 10 mg in 1 mL

Morphine

Injection containing morphine sulfate pentahydrate 15 mg in 1 mL

Morphine

Injection containing morphine sulfate pentahydrate 30 mg in 1 mL

Morphine

Oral solution containing morphine hydrochloride trihydrate 2 mg per mL, 1 mL

Morphine

Oral solution containing morphine hydrochloride trihydrate 5 mg per mL, 1 mL

Morphine

Oral solution containing morphine hydrochloride trihydrate 10 mg per mL, 1 mL

Morphine

Oral solution containing morphine hydrochloride trihydrate 10 mg per mL, 1 mL (S19A)

Morphine

Oral solution containing morphine sulfate 2 mg per mL in 100 mL bottle, 1 mL (S19A)

Morphine

Oral solution containing morphine sulfate 2 mg per mL in 500 mL bottle, 1 mL (S19A)

Morphine

Oral solution containing morphine sulfate 10 mg per 5 mL in 100 mL bottle, 1 mL (S19A)

Morphine

Oral solution containing morphine sulfate 10 mg per 5 mL in 300 mL bottle, 1 mL (S19A)

Morphine

Tablet containing morphine sulfate pentahydrate 10 mg

Morphine

Tablet containing morphine sulfate pentahydrate 20 mg

Morphine

Tablet containing morphine sulfate pentahydrate 5 mg (controlled release)

Morphine

Tablet containing morphine sulfate pentahydrate 10 mg (controlled release)

Morphine

Tablet containing morphine sulfate pentahydrate 15 mg (controlled release)

Morphine

Tablet containing morphine sulfate pentahydrate 30 mg (controlled release)

Morphine

Tablet containing morphine sulfate pentahydrate 60 mg (controlled release)

Morphine

Tablet containing morphine sulfate pentahydrate 100 mg (controlled release)

Morphine

Tablet containing morphine sulfate pentahydrate 200 mg (controlled release)

Oxycodone

Capsule containing oxycodone hydrochloride 5 mg

Oxycodone

Capsule containing oxycodone hydrochloride 10 mg

Oxycodone

Capsule containing oxycodone hydrochloride 20 mg

Oxycodone

Oral solution containing oxycodone hydrochloride 1 mg per mL, 1 mL

Oxycodone

Suppository 30 mg (as pectinate)

Oxycodone

Tablet containing oxycodone hydrochloride 5 mg

Oxycodone

Tablet containing oxycodone hydrochloride 10 mg (controlled release)

Oxycodone

Tablet containing oxycodone hydrochloride 15 mg (controlled release)

Oxycodone

Tablet containing oxycodone hydrochloride 20 mg (controlled release)

Oxycodone

Tablet containing oxycodone hydrochloride 30 mg (controlled release)

Oxycodone

Tablet containing oxycodone hydrochloride 40 mg (controlled release)

Oxycodone

Tablet containing oxycodone hydrochloride 80 mg (controlled release)

Oxycodone with naloxone

Tablet (controlled release) containing oxycodone hydrochloride 2.5 mg with naloxone hydrochloride 1.25 mg

Oxycodone with naloxone

Tablet (controlled release) containing oxycodone hydrochloride 5 mg with naloxone hydrochloride 2.5 mg

Oxycodone with naloxone

Tablet (controlled release) containing oxycodone hydrochloride 10 mg with naloxone hydrochloride 5 mg

Oxycodone with naloxone

Tablet (controlled release) containing oxycodone hydrochloride 15 mg with naloxone hydrochloride 7.5 mg

Oxycodone with naloxone

Tablet (controlled release) containing oxycodone hydrochloride 20 mg with naloxone hydrochloride 10 mg

Oxycodone with naloxone

Tablet (controlled release) containing oxycodone hydrochloride 30 mg with naloxone hydrochloride 15 mg

Oxycodone with naloxone

Tablet (controlled release) containing oxycodone hydrochloride 40 mg with naloxone hydrochloride 20 mg

Oxycodone with naloxone

Tablet (controlled release) containing oxycodone hydrochloride 60 mg with naloxone hydrochloride 30 mg

Oxycodone with naloxone

Tablet (controlled release) containing oxycodone hydrochloride 80 mg with naloxone hydrochloride 40 mg

Tapentadol

Tablet (modified release) 50 mg (as hydrochloride)

Tapentadol

Tablet (modified release) 100 mg (as hydrochloride)

Tapentadol

Tablet (modified release) 150 mg (as hydrochloride)

Tapentadol

Tablet (modified release) 200 mg (as hydrochloride)

Tapentadol

Tablet (modified release) 250 mg (as hydrochloride)

 

Schedule 4Pharmaceutical benefits to be supplied as complete packs only

Note: See section 10.

 

 

 

Pharmaceutical benefits to be supplied as complete packs only

Column 1
Listed drug

Column 2
Form

Abiraterone and methylprednisolone

Pack containing 120 tablets abiraterone acetate 125 mg and 30 tablets methylprednisolone 4 mg

Abiraterone and methylprednisolone

Pack containing 120 tablets abiraterone acetate 125 mg and 60 tablets methylprednisolone 4 mg

Aciclovir

Eye ointment 30 mg per g, 4.5 g

Aclidinium

Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses

Aclidinium with formoterol

Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses

Adapalene with benzoyl peroxide

Gel 1 mg25 mg per g, 30 g

Amoxicillin

Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL

Amoxicillin

Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL

Amoxicillin

Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL

Amoxicillin

Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL

Amoxicillin with clavulanic acid

Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL

Amoxicillin with clavulanic acid

Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 50 mL (S19A)

Amoxicillin with clavulanic acid

Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL

Apremilast

Pack containing 4 tablets 10 mg, 4 tablets 20 mg and 19 tablets 30 mg

Atenolol

Oral solution 50 mg in 10 mL, 300 mL

Atovaquone

Oral suspension 750 mg per 5 mL, 210 mL

Atropine

Eye drops containing atropine sulfate monohydrate 10 mg per mL, 15 mL

Azithromycin

Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL

Beclometasone

Pressurised inhalation containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFCfree formulation)

Beclometasone

Pressurised inhalation containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFCfree formulation)

Beclometasone

Pressurised inhalation in breath actuated device containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFCfree formulation)

Beclometasone

Pressurised inhalation in breath actuated device containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFCfree formulation)

Beclometasone with formoterol

Pressurised inhalation containing beclometasone dipropionate 100 micrograms and formoterol fumarate dihydrate 6 micrograms per dose,120 dose

Beclometasone with formoterol

Pressurised inhalation containing beclometasone dipropionate 200 micrograms and formoterol fumarate dihydrate 6 micrograms per dose, 120 doses

Beclometasone with formoterol and glycopyrronium

Pressurised inhalation containing beclometasone dipropionate 100 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses

Beclometasone with formoterol and glycopyrronium

Pressurised inhalation containing beclometasone dipropionate 200 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses

Benzydamine

Mouth and throat rinse containing benzydamine hydrochloride 22.5 mg per 15 mL, 500 mL

Betaine

Oral powder 180 g

Betaxolol

Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL

Bimatoprost

Eye drops 300 micrograms per mL, 3 mL

Bimatoprost

Eye drops 300 micrograms per mL, single dose units 0.4 mL, 30

Bimatoprost with timolol

Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, 3 mL

Bimatoprost with timolol

Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, single dose units 0.4 mL, 30

Bisacodyl

Enemas 10 mg in 5 mL, 25

Brigatinib

Pack containing 7 tablets 90 mg and 21 tablets 180 mg

Brimonidine

Eye drops containing brimonidine tartrate 1.5 mg per mL, 5 mL

Brimonidine

Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL

Brimonidine with timolol

Eye drops containing brimonidine tartrate 2 mg with timolol 5 mg (as maleate) per mL, 5 mL

Brinzolamide

Eye drops 10 mg per mL, 5 mL

Brinzolamide with brimonidine

Eye drops 10 mg brinzolamide with 2 mg brimonidine tartrate per mL, 5 mL

Brinzolamide with timolol

Eye drops 10 mg brinzolamide with timolol 5 mg (as maleate) per mL, 5 mL

Budesonide

Nebuliser suspension 500 micrograms in 2 mL single dose units, 30

Budesonide

Nebuliser suspension 1 mg in 2 mL single dose units, 30

Budesonide

Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses

Budesonide

Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses

Budesonide

Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses

Budesonide with formoterol

Powder for oral inhalation in breath actuated device containing budesonide 100 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses

Budesonide with formoterol

Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses

Budesonide with formoterol

Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses

Budesonide with formoterol

Pressurised inhalation containing budesonide 50 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses

Budesonide with formoterol

Pressurised inhalation containing budesonide 100 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses

Budesonide with formoterol

Pressurised inhalation containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses

Budesonide with glycopyrronium and formoterol

Pressurised inhalation containing budesonide 160 micrograms with glycopyrronium 7.2 micrograms and formoterol fumarate dihydrate 5 micrograms per dose, 120 doses

Buprenorphine

Injection (modified release) 100 mg in 0.5 mL prefilled syringe

Buprenorphine

Injection (modified release) 300 mg in 1.5 mL prefilled syringe

Calcipotriol with betamethasone

Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g

Calcipotriol with betamethasone

Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g

Captopril

Oral solution 5 mg per mL, 95 mL

Carbamazepine

Oral suspension 100 mg per 5 mL, 300 mL

Carbomer

Eye gel 2 mg per g, 10 g

Carmellose

Eye drops containing carmellose sodium 5 mg per mL, 10 mL

Carmellose

Eye drops containing carmellose sodium 5 mg per mL, 15 mL

Carmellose

Eye drops containing carmellose sodium 10 mg per mL, 15 mL

Carmellose with glycerin

Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, 15 mL

Carmustine

Implants 7.7 mg, 8

Cefaclor

Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Cefaclor

Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

Cefalexin

Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Cefalexin

Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL

Cefuroxime

Powder for oral suspension 125 mg (as axetil) per 5 mL, 70 mL (S19A)

Chloramphenicol

Eye drops 5 mg per mL, 10 mL

Chlorpromazine

Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL

Ciclesonide

Pressurised inhalation 80 micrograms per dose, 120 doses (CFCfree formulation)

Ciclesonide

Pressurised inhalation 160 micrograms per dose, 120 doses (CFCfree formulation)

Ciclosporin

Eye drops 1 mg per mL, single dose units 0.3 mL, 30

Ciprofloxacin

Ear drops 3 mg (as hydrochloride) per mL, 5 mL

Citrulline

Tablet 1 g, 300 (Citrulline Easy)

Clarithromycin

Powder for oral liquid 250 mg per 5 mL, 50 mL

Clobetasol

Shampoo containing clobetasol propionate 500 micrograms per mL, 125 mL

Clonazepam

Oral liquid 2.5 mg per mL, 10 mL

Clozapine

Oral liquid 50 mg per mL, 100 mL

Degarelix

Powder for injection 120 mg (as acetate), 2, injection set

Desmopressin

Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 50 actuations, 5 mL, USP (Apotex)

Desmopressin

Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL

Dexamethasone

Eye drops 1 mg per mL, 5 mL

Dexamethasone with framycetin and gramicidin

Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL

Diazepam

Oral liquid 10 mg per 10 mL, 100 mL

Dorzolamide

Eye drops 20 mg (as hydrochloride) per mL, 5 mL

Dorzolamide with timolol

Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL

Electrolyte replacement, oral

Oral rehydration salts containing glucose monohydrate 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10

Erythromycin

Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL

Erythromycin

Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL

Escitalopram

Oral solution 20 mg (as oxalate) per mL, 15 mL

Esomeprazole and clarithromycin and amoxicillin

Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)

Esomeprazole and clarithromycin and amoxicillin

Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)

Estradiol

Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28

Estradiol

Transdermal patches 390 micrograms, 8

Estradiol

Transdermal patches 585 micrograms, 8

Estradiol

Transdermal patches 780 micrograms, 8

Estradiol

Transdermal patches 1.17 mg, 8

Estradiol

Transdermal patches 1.56 mg, 8

Estradiol

Transdermal patches 2 mg, 4

Estradiol

Transdermal patches 3.8 mg, 4

Estradiol

Transdermal patches 5.7 mg, 4

Estradiol

Transdermal patches 7.6 mg, 4

Estradiol

Transdermal patches 750 micrograms (as hemihydrate), 8

Estradiol

Transdermal patches 1.5 mg (as hemihydrate), 8

Estradiol

Transdermal patches 3 mg (as hemihydrate), 8

Estradiol and estradiol with dydrogesterone

Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg

Estradiol and estradiol with dydrogesterone

Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg

Estradiol and estradiol with norethisterone

Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate

Estradiol and estradiol with norethisterone

Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate

Estradiol with norethisterone

Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8

Estradiol with norethisterone

Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8

Estriol

Pessaries 500 micrograms, 15

Estriol

Vaginal cream 1 mg per g, 15 g

Ethosuximide

Oral solution 250 mg per 5 mL, 200 mL

Ezetimibe and rosuvastatin

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)

Ezetimibe and rosuvastatin

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium)

Ezetimibe and rosuvastatin

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium)

Ezetimibe and rosuvastatin

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium)

Ferrous sulfate

Oral liquid containing 30 mg ferrous sulfate heptahydrate per mL, 250 mL

Flucloxacillin

Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL

Flucloxacillin

Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL

Fluorometholone

Eye drops 1 mg per mL, 5 mL

Fluorometholone

Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL

Fluticasone furoate

Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses

Fluticasone furoate

Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses

Fluticasone furoate with umeclidinium and vilanterol

Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses

Fluticasone furoate with umeclidinium and vilanterol

Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with umeclidinium
62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses

Fluticasone furoate with vilanterol

Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses

Fluticasone furoate with vilanterol

Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses

Fluticasone propionate

Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses

Fluticasone propionate

Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses

Fluticasone propionate

Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses

Fluticasone propionate

Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFCfree formulation)

Fluticasone propionate

Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFCfree formulation)

Fluticasone propionate

Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFCfree formulation)

Fluticasone propionate with formoterol

Pressurised inhalation containing fluticasone propionate 50 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses

Fluticasone propionate with formoterol

Pressurised inhalation containing fluticasone propionate 125 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses

Fluticasone propionate with formoterol

Pressurised inhalation containing fluticasone propionate 250 micrograms with formoterol fumarate dihydrate 10 micrograms per dose, 120 doses

Fluticasone propionate with salmeterol

Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses

Fluticasone propionate with salmeterol

Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses

Fluticasone propionate with salmeterol

Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses

Fluticasone propionate with salmeterol

Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFCfree formulation)

Fluticasone propionate with salmeterol

Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFCfree formulation)

Fluticasone propionate with salmeterol

Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFCfree formulation)

Formoterol

Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 6 micrograms per dose, 60 doses

Formoterol

Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 12 micrograms per dose, 60 doses

Framycetin

Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL

Furosemide

Oral solution 10 mg per mL, 30 mL

Glyceryl trinitrate

Sublingual spray (pump pack) 400 micrograms per dose, 200 doses

Goserelin and bicalutamide

Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in prefilled injection syringe and 28 tablets bicalutamide 50 mg

Goserelin and bicalutamide

Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in prefilled injection syringe and 28 tablets bicalutamide 50 mg

Goserelin and bicalutamide

Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in prefilled injection syringe and 84 tablets bicalutamide 50 mg

Haloperidol

Oral solution 2 mg per mL, 100 mL

Hyaluronic acid

Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL

Hyaluronic acid

Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL

Hydrocortisone

Cream containing hydrocortisone acetate 10 mg per g, 50 g

Hydrocortisone

Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g

Hydrocortisone

Ointment containing hydrocortisone acetate 10 mg per g, 50 g

Hypromellose

0.3% w/v eye drops, 10 mL (preservative free)

Hypromellose

Eye drops 3 mg per mL, 10 mL

Hypromellose

Eye drops 5 mg per mL, 15 mL

Hypromellose with carbomer 980

Ocular lubricating gel 3 mg2 mg per g, 10 g

Hypromellose with dextran

Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL

Ketoconazole

Cream 20 mg per g, 30 g

Lacosamide

Oral solution 10 mg per mL, 200 mL

Larotrectinib

Oral solution 20 mg per mL (as sulfate), 50 mL, 2

Latanoprost

Eye drops 50 micrograms per mL, 2.5 mL

Latanoprost with timolol

Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL

Leuprorelin and bicalutamide

Pack containing 1 syringe containing leuprorelin 7.5 mg (as acetate) and 28 tablets bicalutamide 50 mg

Leuprorelin and bicalutamide

Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 28 tablets bicalutamide 50 mg

Leuprorelin and bicalutamide

Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 84 tablets bicalutamide 50 mg

Levetiracetam

Oral solution 100 mg per mL, 300 mL

Lumacaftor with ivacaftor

Sachet containing granules, lumacaftor 75 mg and ivacaftor 94 mg

Lumacaftor with ivacaftor

Sachet containing granules, lumacaftor 100 mg and ivacaftor 125 mg

Lumacaftor with ivacaftor

Sachet containing granules, lumacaftor 150 mg and ivacaftor 188 mg

Macrogol 3350

Powder for oral solution 510 g

Macrogol 3350

Sachets containing powder for oral solution 13.125 g with electrolytes, 30

Mercaptopurine

Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL

Metronidazole

Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL

Metronidazole

Suppositories 500 mg, 10

Miconazole

Cream containing miconazole nitrate 20 mg per g, 30 g

Miconazole

Cream containing miconazole nitrate 20 mg per g, 70 g

Miconazole

Powder containing miconazole nitrate 20 mg per g, 30 g

Miconazole

Tincture 20 mg per mL, 30 mL

Mifepristone and misoprostol

Pack containing 1 tablet mifepristone 200 mg and 4 tablets misoprostol 200 micrograms

Mupirocin

Nasal ointment 20 mg (as calcium) per g, 3 g

Mupirocin

Nasal ointment 20 mg (as calcium) per g, 5 g

Mycobacterium bovis (Bacillus Calmette and Guerin (BCG)) Danish 1331 strain

Single dose pack containing powder for irrigation 30 mg, 4 vials

Mycophenolic acid

Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL

Nafarelin

Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses

Naloxone

Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2

Naloxone

Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2 (s19A)

Naproxen

Oral suspension 125 mg per 5 mL, 474 mL

Netupitant with palonosetron

Capsule containing netupitant 300 mg with palonosetron 500 microgram (as hydrochloride)

Nicorandil

Tablets 10 mg, 60

Nicorandil

Tablets 20 mg, 60

Nirmatrelvir and ritonavir

Pack containing 4 tablets nirmatrelvir 150 mg and 2 tablets ritonavir 100 mg, 5

Onasemnogene abeparvovec

Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 3 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 4 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 5 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 6 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 7 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 8 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 3 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 4 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 5 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 6 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 7 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 3 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 4 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 5 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 6 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 7 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 8 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Onasemnogene abeparvovec

Pack containing 9 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL

Ondansetron

Syrup 4 mg (as hydrochloride dihydrate) per 5 mL, 50 mL

Oxybutynin

Transdermal patches 36 mg, 8

Ozanimod

Pack containing 4 capsules 230 micrograms and 3 capsules 460 micrograms

Paracetamol

Oral liquid 120 mg per 5 mL, 100 mL

Paracetamol

Oral liquid 240 mg per 5 mL, 200 mL

Paraffin

Eye drops containing liquid paraffin, glycerol, tyloxapol, poloxamer188, trometamol hydrochloride, trometamol, cetalkonium chloride, 10 mL (preservative free)

Paraffin

Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g

Peginterferon beta1a

Pack containing single use injection pens containing 63 micrograms in 0.5 mL and 94 micrograms in 0.5 mL

Permethrin

Cream 50 mg per g, 30 g

Phenytoin

Oral suspension 30 mg per 5 mL, 500 mL

Pilocarpine

Eye drops containing pilocarpine hydrochloride 10 mg per mL, 15 mL

Pilocarpine

Eye drops containing pilocarpine hydrochloride 20 mg per mL, 15 mL

Pilocarpine

Eye drops containing pilocarpine hydrochloride 40 mg per mL, 15 mL

Pimecrolimus

Cream 10 mg per g, 15 g

Polyethylene glycol 400 with propylene glycol

Eye drops 4 mg3 mg per mL, 15 mL

Prednisolone

Oral solution 5 mg (as sodium phosphate) per mL, 30 mL

Prednisolone with phenylephrine

Eye drops containing prednisolone acetate 10 mg with phenylephrine hydrochloride 1.2 mg per mL, 10 mL

Rifampicin

Syrup 100 mg per 5 mL, 60 mL

Risdiplam

Powder for oral solution 750 micrograms per mL, 80 mL

Risperidone

Oral solution 1 mg per mL, 100 mL

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 (S19A)

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30

Salbutamol

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20

Salbutamol

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

Salbutamol

Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFCfree formulation)

Salmeterol

Powder for oral inhalation in breath actuated device 50 micrograms (as xinafoate) per dose, 60 doses

Semaglutide

Solution for injection 2 mg in 1.5 mL prefilled pen

Semaglutide

Solution for injection 4 mg in 3 mL prefilled pen

Silver sulfadiazine

Cream 10 mg per g, 50 g

Sirolimus

Oral solution 1 mg per mL, 60 mL

Tafluprost

Eye drops 15 micrograms per mL, single dose units 0.3 mL, 30

Testosterone

Transdermal cream 50 mg per mL, 50 mL

Testosterone

Transdermal gel 50 mg in 5 g sachet, 30

Testosterone

Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2

Testosterone

Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses

Theophylline

Oral solution 133.3 mg per 25 mL, 500 mL

Timolol

Eye drops 5 mg (as maleate) per mL, 5 mL

Timolol

Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL

Tiotropium

Solution for oral inhalation 2.5 micrograms (as bromide monohydrate) per actuation (60 actuations)

Tiotropium with olodaterol

Solution for oral inhalation containing tiotropium 2.5 micrograms (as bromide monohydrate) with olodaterol 2.5 micrograms (as hydrochloride) per dose, 60 doses

Tobramycin

Eye drops 3 mg per mL, 5 mL

Tobramycin

Eye ointment 3 mg per g, 3.5 g

Tofacitinib

Oral solution 1 mg per mL, 240 mL

Tramadol

Oral drops containing tramadol hydrochloride 100 mg per mL, 10 mL

Travoprost

Eye drops 40 micrograms per mL, 2.5 mL

Travoprost with timolol

Eye drops 40 micrograms travoprost with timolol 5 mg (as maleate) per mL, 2.5 mL

Triamcinolone with neomycin, gramicidin and nystatin

Ear drops containing triamcinolone acetonide 0.9 mg with neomycin 2.25 mg (as sulfate), gramicidin 225 micrograms and nystatin 90,000 units per mL, 7.5 mL

Triamcinolone with neomycin, gramicidin and nystatin

Ear ointment containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 5 g

Trimethoprim with sulfamethoxazole

Paediatric oral suspension 40 mg200 mg per 5 mL, 100 mL

Umeclidinium

Powder for oral inhalation in breath actuated device 62.5 micrograms (as bromide) per dose, 30 doses

Umeclidinium with vilanterol

Powder for oral inhalation in breath actuated device containing umeclidinium 62.5 micrograms (as bromide) with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses

Varenicline

Box containing 11 tablets 0.5 mg (as tartrate) and 14 tablets 1 mg (as tartrate) in the first pack and 28 tablets 1 mg (as tartrate) in the second pack

Venetoclax

Pack containing 14 tablets venetoclax 10 mg and 7 tablets venetoclax 50 mg and 7 tablets venetoclax 100 mg and 14 tablets venetoclax 100 mg

Schedule 5Standard formula preparations

Note: See subsection 7(3).

 

 

1  Standard formula preparations

  Each extemporaneouslyprepared pharmaceutical benefit described in an item of the following table is a standard formula preparation for the purposes of working out the Commonwealth price for supply of the pharmaceutical benefit, unless the benefit:

 (a) varies from what is described in the item because of:

 (i) addition of an ingredient; or

 (ii) omission of an ingredient; or

 (iii) variation of the dose; or

 (b) is a combination of benefits described in 2 or more items of the table.

 

Standard formula preparations

Column 1
Form of pharmaceutical benefit

Column 2
Standard formula preparation

Column 3
Pharmaceutical reference standard

Creams

Salicylic Acid and Sulfur Aqueous

APF

Ear Drops

Aluminium Acetate

APF

Ear Drops

Aluminium Acetate

BP

Ear Drops

Sodium Bicarbonate

APF or BP

Ear Drops

Spirit

APF

Inhalations

Benzoin and Menthol

APF

Inhalations

Menthol

APF

Inhalations

Menthol and Eucalyptus

BP 1980

Linctuses containing Codeine Phosphate

Codeine

APF

Lotions

Aluminium Acetate Aqueous

APF

Mixtures, Other

Kaolin

BPC 1968

Mixtures, Other

Magnesium Trisilicate

BPC 1968

Mixtures, Other

Magnesium Trisilicate and Belladonna

BPC 1968

Ointments, Waxes

Benzoic Acid Compound

APF or BP

Ointments, Waxes

Boric Acid, Olive Oil and Zinc Oxide

QHF

Ointments, Waxes

Salicylic Acid

APF

Ointments, Waxes

Salicylic Acid (extemporaneous formula)

BP

Paints

Podophyllin Compound

APF 16 or BP

Paints

Salicylic Acid

APF

Pastes, Other

Zinc

APF or BP

Powders for Internal Use

Magnesium Trisilicate

BP

Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.

If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.

 

Endnote 2—Abbreviation key

 

ad = added or inserted

o = order(s)

am = amended

Ord = Ordinance

amdt = amendment

orig = original

c = clause(s)

par = paragraph(s)/subparagraph(s)

C[x] = Compilation No. x

/subsubparagraph(s)

Ch = Chapter(s)

pres = present

def = definition(s)

prev = previous

Dict = Dictionary

(prev…) = previously

disallowed = disallowed by Parliament

Pt = Part(s)

Div = Division(s)

r = regulation(s)/rule(s)

ed = editorial change

reloc = relocated

exp = expires/expired or ceases/ceased to have

renum = renumbered

effect

rep = repealed

F = Federal Register of Legislation

rs = repealed and substituted

gaz = gazette

s = section(s)/subsection(s)

LA = Legislation Act 2003

Sch = Schedule(s)

LIA = Legislative Instruments Act 2003

Sdiv = Subdivision(s)

(md) = misdescribed amendment can be given

SLI = Select Legislative Instrument

effect

SR = Statutory Rules

(md not incorp) = misdescribed amendment

SubCh = SubChapter(s)

cannot be given effect

SubPt = Subpart(s)

mod = modified/modification

underlining = whole or part not

No. = Number(s)

commenced or to be commenced

 

Endnote 3—Legislation history

 

Name

Registration

Commencement

Application, saving and transitional provisions

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019)

29 Jan 2020 (F2020L00059)

1 Feb 2020 (s 2(1) item 1)

 

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 1) (PB 22 of 2020)

31 Mar 2020 (F2020L00358)

1 Apr 2020 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 2) (PB 35 of 2020)

30 Apr 2020 (F2020L00536)

1 May 2020 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 3) (PB 43 of 2020)

29 May 2020 (F2020L00644)

1 June 2020 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 4) (PB 57 of 2020)

30 June 2020 (F2020L00853)

1 July 2020 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 5) (PB 69 of 2020)

31 July 2020 (F2020L00969)

1 Aug 2020 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 6) (PB 80 of 2020)

27 Aug 2020 (F2020L01071)

1 Sept 2020 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 7) (PB 104 of 2020)

30 Oct 2020 (F2020L01371)

1 Nov 2020 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 8) (PB 113 of 2020)

27 Nov 2020 (F2020L01486)

1 Dec 2020 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 9) (PB 126 of 2020)

23 Dec 2020 (F2020L01689)

1 Jan 2021 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 1) (PB 15 of 2021)

25 Feb 2021 (F2021L00154)

1 Mar 2021 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 2) (PB 24 of 2021)

31 Mar 2021 (F2021L00399)

1 Apr 2021 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 3) (PB 40 of 2021)

30 Apr 2021 (F2021L00519)

1 May 2021 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 4) (PB 48 of 2021)

28 May 2021 (F2021L00662)

1 June 2021 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 5) (PB 62 of 2021)

30 June 2021 (F2021L00905)

1 July 2021 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 6) (PB 76 of 2021)

31 July 2021 (F2021L01059)

1 Aug 2021 (s 2)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 7) (PB 89 of 2021)

31 Aug 2021 (F2021L01216)

1 Sept 2021 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 8) (PB 99 of 2021)

30 Sept 2021 (F2021L01350)

1 Oct 2021 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 9) (PB 111 of 2021)

31 Oct 2021 (F2021L01493)

1 Nov 2021 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 1) (PB 25 of 2022)

31 Mar 2022 (F2022L00450)

1 Apr 2022 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 2) (PB 35 of 2022)

29 Apr 2022 (F2022L00645)

1 May 2022 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 3) (PB 45 of 2022)

27 May 2022 (F2022L00726)

1 June 2022 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 4) (PB 56 of 2022)

29 June 2022 (F2022L00873)

1 July 2022 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 5) (PB 69 of 2022)

29 July 2022 (F2022L01021)

1 Aug 2022 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 6) (PB 87 of 2022)

30 Sept 2022 (F2022L01305)

1 Oct 2022 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 7) (PB 101 of 2022)

31 Oct 2022 (F2022L01411)

1 Nov 2022 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 113 of 2022)

30 Nov 2022 (F2022L01547)

1 Dec 2022 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2022 (No. 9) (PB 122 of 2022)

23 Dec 2022 (F2022L01756)

1 Jan 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No.1) (PB 3 of 2023)

31 Jan 2023 (F2023L00073)

1 Feb 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No.2) (PB 12 of 2023)

28 Feb 2023 (F2023L00161)

1 Mar 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No.3) (PB 23 of 2023)

31 Mar 2023 (F2023L00388)

1 Apr 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No.4) (PB 36 of 2023)

28 Apr 2023 (F2023L00503)

1 May 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No.5) (PB 45 of 2023)

31 May 2023 (F2023L00654)

1 June 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No.6) (PB 56 of 2023)

30 June 2023 (F2023L00925)

1 July 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No. 7) (PB 69 of 2023)

31 July 2023 (F2023L01052)

1 Aug 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No. 8) (PB 81 of 2023)

31 Aug 2023 (F2023L01151)

1 Sept 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No. 9) (PB 93 of 2023)

29 Sept 2023 (F2023L01335)

1 Oct 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No. 10) (PB 106 of 2023)

31 Oct 2023 (F2023L01453)

1 Nov 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No. 11) (PB 114 of 2023)

30 Nov 2023 (F2023L01582)

1 Dec 2023 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2023 (No. 12) (PB 130 of 2023)

22 Dec 2023 (F2023L01749)

1 Jan 2024 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2024 (No. 1) (PB 3 of 2024)

31 Jan 2024 (F2024L00123)

1 Feb 2024 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2024 (No. 2) (PB 17 of 2024)

29 Feb 2024 (F2024L00240)

1 Mar 2024 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2024 (No. 3) (PB 28 of 2024)

28 Mar 2024 (F2024L00409)

1 Apr 2024 (s 2(1) item 1)

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2024 (No. 4) (PB 41 of 2024)

30 Apr 2024 (F2024L00500)

1 May 2024 (s 2(1) item 1)

 

Endnote 4—Amendment history

 

Provision affected

How affected

Part 1

 

s 2.....................

rep LA s 48D

s 4.....................

rep LA s 48C

s 6.....................

am F2020L00853

 

ed C4

Part 2

 

s 7.....................

am F2020L00853

 

ed C4

Schedule 1

 

Schedule 1................

am F2023L00161; F2023L00654; F2023L01335; F2023L01453; F2023L01582; F2024L00500

Schedule 3

 

Schedule 3................

am F2020L01071; F2021L00905; F2022L00726; F2022L01021; F2023L00073; F2023L00503; F2023L00925; F2023L01052; F2023L01582; F2023L01749; F2024L00240; F2024L00409

Schedule 4

 

Schedule 4................

am F2020L00358; F2020L00536; F2020L00644; F2020L00853; F2020L00969; F2020L01371; F2020L01486; F2020L01689; F2021L00154; F2021L00399; F2021L00519; F2021L00662; F2021L01059; F2021L01216; F2021L01350; F2021L01493; F2022L00450; F2022L00645; F2022L00873; F2022L01021; F2022L01305; F2022L01411; F2022L01547; F2022L01756; F2023L00073; F2023L00161; F2023L00388; F2023L00503; F2023L00654; F2023L00925; F2023L01052; F2023L01151; F2023L01335; F2023L01453; F2023L01582; F2023L01749; F2024L00123; F2024L00240; F2024L00409; F2024L00500

Schedule 5

 

Schedule 5................

am F2021L01059

Schedule 6................

rep LA s 48C